Alexandria Real Estate Equities, Inc. Q3 2025 Earnings Recap

ARE Q3 2025 October 29, 2025

Get alerts when ARE reports next quarter

Alexandria Real Estate Equities reported challenges in Q3 2025, with declines in FFO per share and occupancy, but remains strategically positioned for recovery in the life science sector and maintains a strong balance sheet.

Earnings Per Share Miss

$2.22 vs $2.31 est.

-3.9% surprise

Revenue Miss

735849000 vs 744876570 est.

-1.2% surprise

Market Reaction

1-Day -4.07%

5-Day -7.3%

30-Day -9.63%

See ARE alongside your other holdings

Add to your portfolio — free

Key Takeaways

FFO per share declined, coupled with a decrease in occupancy, signaling a need for continued vigilance in asset management.
Alexandria's balance sheet is one of the strongest among REITs, with an average remaining debt maturity of 11.6 years and over $4 billion in liquidity.
The company aims to reduce non-income-producing assets from 20% to 10-15% of gross assets, drawing on lessons from past market disruptions.
Early signs of recovery in the biotech market are emerging, amidst ongoing regulatory challenges faced by the FDA due to the government shutdown.
Alexandria emphasizes its unique position in the life science real estate market, navigating current headwinds with resilience and strategic foresight.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit ARE on AllInvestView.

Next Q1 2026